Multifunctionalized reduced graphene oxide biosensors for simultaneous monitoring of structural changes in amyloid-β 40

Dahye Jeong, Jinsik Kim, Myung Sic Chae, Wonseok Lee, Seung Hoon Yang, Youngsoo Kim, Seung Min Kim, Jin San Lee, Jeong Hoon Lee, Jungkyu Choi, Dae Sung Yoon, Kyo Seon Hwang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Determination of the conformation (monomer, oligomer, or fibril) of amyloid peptide aggregates in the human brain is essential for the diagnosis and treatment of Alzheimer’s disease (AD). Accordingly, systematic investigation of amyloid conformation using analytical tools is essential for precisely quantifying the relative amounts of the three conformations of amyloid peptide. Here, we developed a reduced graphene oxide (rGO) based multiplexing biosensor that could be used to monitor the relative amounts of the three conformations of various amyloid-β 40 (Aβ40) fluids. The electrical rGO biosensor was composed of a multichannel sensor array capable of individual detection of monomers, oligomers, and fibrils in a single amyloid fluid sample. From the performance test of each sensor, we showed that this method had good analytical sensitivity (1 pg/mL) and a fairly wide dynamic range (1 pg/mL to 10 ng/mL) for each conformation of Aβ40. To verify whether the rGO biosensor could be used to evaluate the relative amounts of the three conformations, various amyloid solutions (monomeric Aβ40, aggregated Aβ40, and disaggregated Aβ40 solutions) were employed. Notably, different trends in the relative amounts of the three conformations were observed in each amyloid solution, indicating that this information could serve as an important parameter in the clinical setting. Accordingly, our analytical tool could precisely detect the relative amounts of the three conformations of Aβ40 and may have potential applications as a diagnostic system for AD.

Original languageEnglish
Article number1738
JournalSensors (Switzerland)
Volume18
Issue number6
DOIs
Publication statusPublished - 2018 Jun 1

Fingerprint

Graphite
Biosensing Techniques
bioinstrumentation
Amyloid
Biosensors
Oxides
Graphene
graphene
oligomers
peptides
oxides
Conformations
Monitoring
monomers
performance tests
fluids
sensors
multiplexing
dynamic range
brain

Keywords

  • Alzheimer’s disease
  • Amyloid beta
  • Biosensor
  • Reduced graphene oxide(rGO)

ASJC Scopus subject areas

  • Analytical Chemistry
  • Atomic and Molecular Physics, and Optics
  • Biochemistry
  • Instrumentation
  • Electrical and Electronic Engineering

Cite this

Multifunctionalized reduced graphene oxide biosensors for simultaneous monitoring of structural changes in amyloid-β 40. / Jeong, Dahye; Kim, Jinsik; Chae, Myung Sic; Lee, Wonseok; Yang, Seung Hoon; Kim, Youngsoo; Kim, Seung Min; Lee, Jin San; Lee, Jeong Hoon; Choi, Jungkyu; Yoon, Dae Sung; Hwang, Kyo Seon.

In: Sensors (Switzerland), Vol. 18, No. 6, 1738, 01.06.2018.

Research output: Contribution to journalArticle

Jeong, Dahye ; Kim, Jinsik ; Chae, Myung Sic ; Lee, Wonseok ; Yang, Seung Hoon ; Kim, Youngsoo ; Kim, Seung Min ; Lee, Jin San ; Lee, Jeong Hoon ; Choi, Jungkyu ; Yoon, Dae Sung ; Hwang, Kyo Seon. / Multifunctionalized reduced graphene oxide biosensors for simultaneous monitoring of structural changes in amyloid-β 40. In: Sensors (Switzerland). 2018 ; Vol. 18, No. 6.
@article{875add86f1924b3fa1c8c8ca0bc58a80,
title = "Multifunctionalized reduced graphene oxide biosensors for simultaneous monitoring of structural changes in amyloid-β 40",
abstract = "Determination of the conformation (monomer, oligomer, or fibril) of amyloid peptide aggregates in the human brain is essential for the diagnosis and treatment of Alzheimer’s disease (AD). Accordingly, systematic investigation of amyloid conformation using analytical tools is essential for precisely quantifying the relative amounts of the three conformations of amyloid peptide. Here, we developed a reduced graphene oxide (rGO) based multiplexing biosensor that could be used to monitor the relative amounts of the three conformations of various amyloid-β 40 (Aβ40) fluids. The electrical rGO biosensor was composed of a multichannel sensor array capable of individual detection of monomers, oligomers, and fibrils in a single amyloid fluid sample. From the performance test of each sensor, we showed that this method had good analytical sensitivity (1 pg/mL) and a fairly wide dynamic range (1 pg/mL to 10 ng/mL) for each conformation of Aβ40. To verify whether the rGO biosensor could be used to evaluate the relative amounts of the three conformations, various amyloid solutions (monomeric Aβ40, aggregated Aβ40, and disaggregated Aβ40 solutions) were employed. Notably, different trends in the relative amounts of the three conformations were observed in each amyloid solution, indicating that this information could serve as an important parameter in the clinical setting. Accordingly, our analytical tool could precisely detect the relative amounts of the three conformations of Aβ40 and may have potential applications as a diagnostic system for AD.",
keywords = "Alzheimer’s disease, Amyloid beta, Biosensor, Reduced graphene oxide(rGO)",
author = "Dahye Jeong and Jinsik Kim and Chae, {Myung Sic} and Wonseok Lee and Yang, {Seung Hoon} and Youngsoo Kim and Kim, {Seung Min} and Lee, {Jin San} and Lee, {Jeong Hoon} and Jungkyu Choi and Yoon, {Dae Sung} and Hwang, {Kyo Seon}",
year = "2018",
month = "6",
day = "1",
doi = "10.3390/s18061738",
language = "English",
volume = "18",
journal = "Sensors (Switzerland)",
issn = "1424-8220",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "6",

}

TY - JOUR

T1 - Multifunctionalized reduced graphene oxide biosensors for simultaneous monitoring of structural changes in amyloid-β 40

AU - Jeong, Dahye

AU - Kim, Jinsik

AU - Chae, Myung Sic

AU - Lee, Wonseok

AU - Yang, Seung Hoon

AU - Kim, Youngsoo

AU - Kim, Seung Min

AU - Lee, Jin San

AU - Lee, Jeong Hoon

AU - Choi, Jungkyu

AU - Yoon, Dae Sung

AU - Hwang, Kyo Seon

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Determination of the conformation (monomer, oligomer, or fibril) of amyloid peptide aggregates in the human brain is essential for the diagnosis and treatment of Alzheimer’s disease (AD). Accordingly, systematic investigation of amyloid conformation using analytical tools is essential for precisely quantifying the relative amounts of the three conformations of amyloid peptide. Here, we developed a reduced graphene oxide (rGO) based multiplexing biosensor that could be used to monitor the relative amounts of the three conformations of various amyloid-β 40 (Aβ40) fluids. The electrical rGO biosensor was composed of a multichannel sensor array capable of individual detection of monomers, oligomers, and fibrils in a single amyloid fluid sample. From the performance test of each sensor, we showed that this method had good analytical sensitivity (1 pg/mL) and a fairly wide dynamic range (1 pg/mL to 10 ng/mL) for each conformation of Aβ40. To verify whether the rGO biosensor could be used to evaluate the relative amounts of the three conformations, various amyloid solutions (monomeric Aβ40, aggregated Aβ40, and disaggregated Aβ40 solutions) were employed. Notably, different trends in the relative amounts of the three conformations were observed in each amyloid solution, indicating that this information could serve as an important parameter in the clinical setting. Accordingly, our analytical tool could precisely detect the relative amounts of the three conformations of Aβ40 and may have potential applications as a diagnostic system for AD.

AB - Determination of the conformation (monomer, oligomer, or fibril) of amyloid peptide aggregates in the human brain is essential for the diagnosis and treatment of Alzheimer’s disease (AD). Accordingly, systematic investigation of amyloid conformation using analytical tools is essential for precisely quantifying the relative amounts of the three conformations of amyloid peptide. Here, we developed a reduced graphene oxide (rGO) based multiplexing biosensor that could be used to monitor the relative amounts of the three conformations of various amyloid-β 40 (Aβ40) fluids. The electrical rGO biosensor was composed of a multichannel sensor array capable of individual detection of monomers, oligomers, and fibrils in a single amyloid fluid sample. From the performance test of each sensor, we showed that this method had good analytical sensitivity (1 pg/mL) and a fairly wide dynamic range (1 pg/mL to 10 ng/mL) for each conformation of Aβ40. To verify whether the rGO biosensor could be used to evaluate the relative amounts of the three conformations, various amyloid solutions (monomeric Aβ40, aggregated Aβ40, and disaggregated Aβ40 solutions) were employed. Notably, different trends in the relative amounts of the three conformations were observed in each amyloid solution, indicating that this information could serve as an important parameter in the clinical setting. Accordingly, our analytical tool could precisely detect the relative amounts of the three conformations of Aβ40 and may have potential applications as a diagnostic system for AD.

KW - Alzheimer’s disease

KW - Amyloid beta

KW - Biosensor

KW - Reduced graphene oxide(rGO)

UR - http://www.scopus.com/inward/record.url?scp=85047861362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047861362&partnerID=8YFLogxK

U2 - 10.3390/s18061738

DO - 10.3390/s18061738

M3 - Article

C2 - 29843431

AN - SCOPUS:85047861362

VL - 18

JO - Sensors (Switzerland)

JF - Sensors (Switzerland)

SN - 1424-8220

IS - 6

M1 - 1738

ER -